Lock، E. A.؛ Ellis، M. K.؛ Gaskin، P.؛ Robinson، M.؛ Auton، T. R.؛ Provan، W. M.؛ Smith، L. L.؛ Prisbylla، M. P.؛ Mutter، L. C.؛ Lee، D. L. (1998). "From toxicological problem to therapeutic use: The discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug". Journal of Inherited Metabolic Disease. ج. 21 ع. 5: 498–506. DOI:10.1023/A:1005458703363. PMID:9728330.
Kavana، Michael؛ Moran، Graham R. (2003). "Interaction of (4-Hydroxyphenyl)pyruvate Dioxygenase with the Specific Inhibitor 2-[2-Nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione†". Biochemistry. ج. 42 ع. 34: 10238–45. DOI:10.1021/bi034658b. PMID:12939152.
Lock، E. A.؛ Ellis، M. K.؛ Gaskin، P.؛ Robinson، M.؛ Auton، T. R.؛ Provan، W. M.؛ Smith، L. L.؛ Prisbylla، M. P.؛ Mutter، L. C.؛ Lee، D. L. (1998). "From toxicological problem to therapeutic use: The discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug". Journal of Inherited Metabolic Disease. ج. 21 ع. 5: 498–506. DOI:10.1023/A:1005458703363. PMID:9728330.
Kavana، Michael؛ Moran، Graham R. (2003). "Interaction of (4-Hydroxyphenyl)pyruvate Dioxygenase with the Specific Inhibitor 2-[2-Nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione†". Biochemistry. ج. 42 ع. 34: 10238–45. DOI:10.1021/bi034658b. PMID:12939152.